As of April 22, 2026, Champions Oncology's top three insider holders are Joel Ackerman (Chief Executive Officer, 1.06Mn shares), Ronnie Morris (Ceo, 858.88K shares), David Sidransky (Director, 767.04K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Joel Ackerman | Chief Executive Officer | 1,056,539 | 0 | 30 Oct, 2025 |
| Ronnie Morris | Ceo | 858,878 | 0 | 21 Mar, 2023 |
| David Sidransky | - | 767,043 | 0 | 12 Oct, 2022 |
| Daniel Newman Mendelson | - | 198,625 | 0 | 16 Jan, 2024 |
| Scott R Tobin | - | 30,000 | 0 | 12 Oct, 2022 |
| Philip P. Breitfeld | - | 5,717 | 0 | 02 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Nov, 2025 | Joel Ackerman | Option to purchase Common Stock | A | 21,216 | $6.80 | 21,216 | D | A |
| 05 Nov, 2025 | Philip P. Breitfeld | Option to purchase Common Stock | A | 13,790 | $6.80 | 13,790 | D | A |
| 05 Nov, 2025 | David Sidransky | Option to purchase Common Stock | A | 21,216 | $6.80 | 21,216 | D | A |
| 05 Nov, 2025 | Scott R Tobin | Option to purchase Common Stock | A | 25,460 | $6.80 | 25,460 | D | A |
| 05 Nov, 2025 | Daniel Newman Mendelson | Option to purchase Common Stock | A | 13,790 | $6.80 | 13,790 | D | A |
| 30 Oct, 2025 | Joel Ackerman | Common Stock | A | 94,405 | $2.10 | 1,056,539 | D | M |
| 30 Oct, 2025 | Joel Ackerman | Option to purchase Common Stock | D | 94,405 | $2.10 | 0 | D | M |
| 25 Mar, 2025 | Philip P. Breitfeld | Common Stock | D | 4,150 | $0.00 | 5,717 | D | J |
| 12 Nov, 2024 | Scott R Tobin | Option to purchase Common Stock | A | 34,550 | $4.64 | 34,550 | D | A |
| 12 Nov, 2024 | Philip P. Breitfeld | Option to purchase Common Stock | A | 18,715 | $4.64 | 18,715 | D | A |
| 12 Nov, 2024 | Joel Ackerman | Option to purchase Common Stock | A | 43,190 | $4.64 | 43,190 | D | A |
| 12 Nov, 2024 | David Sidransky | Option to purchase Common Stock | A | 21,880 | $4.64 | 21,880 | D | A |
| 12 Nov, 2024 | Daniel Newman Mendelson | Option to purchase Common Stock | A | 21,590 | $4.64 | 21,590 | D | A |
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 88,470 | $2.10 | 945,467 | D | M |
| 31 Oct, 2024 | Joel Ackerman | Common Stock | A | 16,667 | $5.43 | 962,134 | D | M |
| 31 Oct, 2024 | Joel Ackerman | Option to purchase Common Stock | D | 88,470 | $2.10 | 0 | D | M |
| 31 Oct, 2024 | Joel Ackerman | Option to purchase Common Stock | D | 16,667 | $5.43 | 0 | D | M |
| 12 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 1,000 | $6.50 | 198,625 | D | P |
| 11 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 2,000 | $6.27 | 197,625 | D | P |
| 10 Jan, 2024 | Daniel Newman Mendelson | Common Stock | A | 2,944 | $6.31 | 195,625 | D | P |